Your browser doesn't support javascript.
loading
Patients with Fabry Disease after Enzyme Replacement Therapy Dose Reduction and Switch-2-Year Follow-Up.
Lenders, Malte; Canaan-Kühl, Sima; Krämer, Johannes; Duning, Thomas; Reiermann, Stefanie; Sommer, Claudia; Stypmann, Jörg; Blaschke, Daniela; Üçeyler, Nurcan; Hense, Hans-Werner; Brand, Stefan-Martin; Wanner, Christoph; Weidemann, Frank; Brand, Eva.
Afiliación
  • Lenders M; Internal Medicine D, Department of Nephrology, Hypertension and Rheumatology, Interdisciplinary Fabry Center Münster.
  • Canaan-Kühl S; Department of Medicine, Division of Nephrology and.
  • Krämer J; Department of Pediatrics and Adolescent Medicine, University of Ulm, Ulm, Germany; Department of Medicine, Divisions of Cardiology and Nephrology, Comprehensive Heart Failure Center, Fabry Center for Interdisciplinary Therapy and.
  • Duning T; Department of Neurology.
  • Reiermann S; Internal Medicine D, Department of Nephrology, Hypertension and Rheumatology, Interdisciplinary Fabry Center Münster.
  • Sommer C; Department of Medicine, Divisions of Cardiology and Nephrology, Comprehensive Heart Failure Center, Fabry Center for Interdisciplinary Therapy and Department of Neurology, University of Würzburg, Würzburg, Germany;
  • Stypmann J; Department of Cardiovascular Medicine, Division of Cardiology.
  • Blaschke D; Department of Medicine, Division of Cardiology, Charité, Campus Virchow-Klinikum, Berlin, Germany;
  • Üçeyler N; Department of Medicine, Divisions of Cardiology and Nephrology, Comprehensive Heart Failure Center, Fabry Center for Interdisciplinary Therapy and Department of Neurology, University of Würzburg, Würzburg, Germany;
  • Hense HW; Institute of Epidemiology and Social Medicine, and.
  • Brand SM; Institute of Sports Medicine, Molecular Genetics of Cardiovascular Disease, University Hospital Münster, Münster, Germany;
  • Wanner C; Department of Medicine, Divisions of Cardiology and Nephrology, Comprehensive Heart Failure Center, Fabry Center for Interdisciplinary Therapy and.
  • Weidemann F; Department of Medicine, Divisions of Cardiology and Nephrology, Comprehensive Heart Failure Center, Fabry Center for Interdisciplinary Therapy and Katharinen-Hospital Unna, Unna, Germany.
  • Brand E; Internal Medicine D, Department of Nephrology, Hypertension and Rheumatology, Interdisciplinary Fabry Center Münster, Eva.Brand@ukmuenster.de.
J Am Soc Nephrol ; 27(3): 952-62, 2016 Mar.
Article en En | MEDLINE | ID: mdl-26185201
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de Fabry / Alfa-Galactosidasa / Insuficiencia Renal Crónica / Tasa de Filtración Glomerular / Isoenzimas Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Am Soc Nephrol Asunto de la revista: NEFROLOGIA Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de Fabry / Alfa-Galactosidasa / Insuficiencia Renal Crónica / Tasa de Filtración Glomerular / Isoenzimas Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Am Soc Nephrol Asunto de la revista: NEFROLOGIA Año: 2016 Tipo del documento: Article